Press Releases/Recent News
July 27, 2010
MABCURE ANNOUNCES POSITIVE RESULTS FOR NEW OVARIAN CANCER DIAGNOSTIC BLOOD TEST
June 1, 2010
MEMORANDUM TO SHAREHOLDERS FROM DR. AMNON GONENNE, MABCURE’S CHIEF EXECUTIVE OFFICER
March 31, 2010
MABCURE CEO ARTICLE FEATURED IN THE APRIL ISSUE OF "DRUG DISCOVERY NEWS"
February 1, 2010
January 6, 2010
MABCURE LAUNCHES CLINICAL TRIAL TO DIAGNOSE OVARIAN CANCER
November 4, 2009
MABCURE SIGNS RESEARCH AGREEMENT WITH BRUGGE, BELGIUM HOSPITAL
September 29, 2009
MABCURE PRODUCES MONOCLONAL ANTIBODIES AGAINST COLORECTAL CANCER
September 1, 2009
MABCURE CEO ARTICLE FEATURED IN THE SEPTEMBER ISSUE OF GENŽ
August 25, 2009
MABCURE FEATURED IN BIOWORLDŽ TODAY
August 18, 2009
ARTICLE BY MABCURE CEO -- TUMOUR-SPECIFIC MARKERS: THE HOLY GRAIL OF CANCER DIAGNOSTICS
August 7, 2009
MABCURE APPEARS IN ARTICLE ON "THE USE OF BIOMOLECULES IN DIAGNOSTIC TESTING
May 28, 2009
[Video] PRESIDENT & CEO OF MABCURE, DR. AMNON GONENNE, TALKS ABOUT MABCURE AND ITS TECHONOLGY
April 27, 2009
MABCURE WELCOMES DR. DAVID S. FRANK AS NEW MEMBER OF THE BOARD OF DIRECTORS
April 1, 2009
MABCURE ESTABLISHES RESEARCH FACILITIES ON THE CAMPUS OF HASSELT UNIVERSITY
October 30th, 2008
MABCURE ESTABLISHES BELGIAN SUBSIDIARY AND RELOCATES HEADQUARTERS TO BELGIUM
July 11th, 2008
MABCURE COMPLETES KEY ACQUISITION
June 27th, 2008
MABCURE CLOSES US $1.3 MILLION PRIVATE PLACEMENT
November 30, 2007
SMARTEC ACQUIRES TECHNOLOGY FOR DETECTING EARLY STAGE CANCERS